We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMH icon
101
VanEck Semiconductor ETF
SMH
$70.9B
$815K 0.08%
+8,000
New +$929K
DNAB
102
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$809K 0.08%
83,220
+25,000
+43% +$243K
CTLP
103
PUT
DELISTED
Cantaloupe
CTLP
$802K 0.08%
1,100,000
+1,000,000
+1,000% +$5.31M
HAL icon
104
Halliburton
HAL
$28B
$784K 0.08%
24,986
-2,895
-10% -$108K
AAPL icon
105
Apple
AAPL
$4.48T
$752K 0.07%
+5,500
New +$833K
AGIO icon
106
PUT
Agios Pharmaceuticals
AGIO
$1.94B
$718K 0.07%
30,000
JPM icon
107
JPMorgan Chase
JPM
$953B
$707K 0.07%
+6,275
New +$777K
AAGR
108
DELISTED
African Agriculture Holdings Inc
AAGR
$700K 0.07%
+98,567
New +$698K
PRG icon
109
PUT
PROG Holdings
PRG
$1.7B
$697K 0.07%
+50,000
New +$1.28M
LAZR
110
PUT
DELISTED
Luminar Technologies
LAZR
$681K 0.07%
+40,753
New +$6.51M
KVSA
111
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$663K 0.06%
68,000
FITB
112
Fifth Third Bancorp
FITB
$51.7B
$618K 0.06%
18,378
-6,645
-27% -$250K
AGIO icon
113
Agios Pharmaceuticals
AGIO
$1.94B
$602K 0.06%
27,132
+6,382
+31% +$144K
AWAY icon
114
Amplify Travel Tech ETF
AWAY
$32.4M
$600K 0.06%
34,210
-9,908
-22% -$204K
BRSL
115
Brightstar Lottery PLC
BRSL
$2.03B
$585K 0.06%
+31,532
New +$672K
LCID icon
116
Lucid Motors
LCID
$2.6B
$563K 0.05%
3,280
-5,190
-61% -$986K
VG
117
DELISTED
Vonage Holdings Corporation
VG
$563K 0.05%
+29,900
New +$572K
AFACW
118
DELISTED
Arena Fortify Acquisition Corp. Warrant
AFACW
$545K 0.05%
545,000
KSS icon
119
Kohl's
KSS
$2.19B
$540K 0.05%
+15,131
New +$742K
BSGA
120
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
$540K 0.05%
53,401
FPAC
121
DELISTED
Far Peak Acquisition Corporation
FPAC
$540K 0.05%
+55,000
New +$542K
DIA icon
122
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.3B
$539K 0.05%
1,750
-1,430
-45% -$468K
MGV icon
123
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.6B
$538K 0.05%
+5,590
New +$572K
MGK icon
124
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
$535K 0.05%
+14,725
New +$592K
KRE icon
125
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.55B
$523K 0.05%
75,000

Similar funds

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.